
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Living Cell Technologies is a biotechnology business based in Australia. Living Cell Technologies shares (LCT) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Living Cell Technologies has a trailing 12-month revenue of around $155,368. If you're looking to buy shares, check out the steps below.
How to buy shares in Living Cell Technologies
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Living Cell Technologies . Find the share by name or ticker symbol: LCT. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Living Cell Technologies reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Living Cell Technologies . Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
Our top pick for
US stocks

Our top pick for
Overall broker

Our top pick for
Low-cost broker

What's in this guide?
- Living Cell Technologies key stats
- Compare share trading platforms
- Is Living Cell Technologies stock a buy or sell?
- Living Cell Technologies performance over time
- Living Cell Technologies 's financials
- How volatile are Living Cell Technologies shares?
- Does Living Cell Technologies pay a dividend?
- Other common questions
Living Cell Technologies stock price (ASX:LCT)
Use our graph to track the performance of LCT stocks over time.Living Cell Technologies shares at a glance
52-week range | $0.0045 - $0.016 |
---|---|
50-day moving average | $0.0065 |
200-day moving average | $0.0068 |
Target price | N/A |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.003 |
Compare share trading platforms
Is it a good time to buy Living Cell Technologies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Living Cell Technologies price performance over time
Historical closes compared with the last close of A$0.009
1 week (2022-06-29) | 0.009 |
---|---|
1 month (2022-06-06) | 28.57% |
3 months (2022-04-06) | 28.57% |
6 months (2022-01-06) | 80.00% |
1 year (2021-07-06) | -35.71% |
---|---|
2 years (2020-07-06) | -40.00% |
3 years (2019-07-05) | -60.87% |
5 years (2017-07-06) | -91.43% |
Living Cell Technologies financials
Revenue TTM | $155,368 |
---|---|
Gross profit TTM | $268,184 |
Return on assets TTM | -24.03% |
Return on equity TTM | -48.81% |
Profit margin | 0% |
Book value | 0.004 |
Market capitalisation | $11.6 million |
TTM: trailing 12 months
Living Cell Technologies share dividends
We're not expecting Living Cell Technologies to pay a dividend over the next 12 months.
Living Cell Technologies share price volatility
Over the last 12 months, Living Cell Technologies 's shares have ranged in value from as little as $0.0045 up to $0.016. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Living Cell Technologies 's is 0.7102. This would suggest that Living Cell Technologies 's shares are less volatile than average (for this exchange).
Living Cell Technologies overview
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.
Stocks similar to Living Cell Technologies
Living Cell Technologies in the news
Frequently asked questions
More guides on Finder
-
How to invest in the Octava Minerals IPO
Everything we know about the Octava Minerals IPO, plus information on how to buy in.
-
How to invest in the Australia Sunny Glass Group IPO
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
-
How to buy Kincora Copper (KCC) shares
Steps to owning and managing Kincora Copper shares.
-
How to invest in the Dragon Mountain Gold IPO
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
-
How to buy Arcadia Minerals (AM7) shares
Steps to owning and managing Arcadia Minerals shares.
-
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
-
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
-
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
-
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
-
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
Ask an Expert